no statement of use filed
on 14 Feb 2022
Last Applicant/ Owned by
2330 Inwood Road, Suite 226
Dallas
TX
752357323
Serial Number
88225205 filed on 11th Dec 2018
Registration Number
N/A
Correspondent Address
Lisa M. Dellamura
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"THERAPEUTICS"
"THERAPEUTICS" Pharmaceutical preparations for the treatment of cancerous diseases, inflammation, metabolic diseases, pulmonary hypertension and inflammatory bowel disease; Pharmaceutical preparations for use in the field of oncology; pharmaceutical preparations, namely, medicines for human consumption taken orally for treatment of cancerous diseases, inflammation, metabolic diseases, pulmonary hRead More
Pharmaceutical preparations for the treatment of cancerous diseases, inflammation, metabolic diseases, pulmonary hypertension and inflammatory bowel disease; Pharmaceutical preparations for use in the field of oncology; pharmaceutical preparations, namely, medicines for human consumption taken orally for treatment of cancerous diseases, inflammation, metabolic diseases, pulmonary hypertension, inflammatory diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-inflammatories, anti-virals, anti-infectives, immunosuppressants and pharmaceutical antibodies
Pharmaceutical research and development services for research and development of human pharmaceutical preparations
No 88225205
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
14th Feb 2022 | ABANDONMENT - NO USE STATEMENT FILED |
14th Feb 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
18th Jan 2022 | ASSIGNED TO EXAMINER |
09th Jul 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
07th Jul 2021 | EXTENSION 4 FILED |
07th Jul 2021 | TEAS EXTENSION RECEIVED |
07th Jul 2021 | EXTENSION 4 GRANTED |
10th Jun 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
10th Jun 2021 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
10th Jun 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |